Cerner Corporation and Abbott Laboratories (NYSE: ABT) yesterday announced an exclusive agreement to develop and co-market a comprehensive new point-of-care medication management system for infusion therapy. The system will integrate point-of-care infusion and diagnostic medical devices, bar coding, clinical information and knowledge-based decision support tools at the patient's bedside. It will facilitate improved patient safety, clinical outcomes and cost management, as well as caregiver efficiency and effectiveness.
Initially, the system will aim to improve patient safety in infusion thera...
Comments